Cognition Therapeutics Inc (CGTX)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.63
- As of
Kresmion compiles this page from CGTX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
COGNITION THERAPEUTICS INC (CGTX): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q3 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-05.
See the full CGTX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CGTX on one page. Preview it with sample data, then open it live with a free account.
Preview the CGTX dossierActive events for CGTX
- mediumEarnings above estimates
Q3-2026: Beat consensus by 41.2%, EPS $-0.04 vs $-0.068 estimate
- mediumEarnings above estimates
Q2-2026: Beat consensus by 38.1%, EPS $-0.04 vs $-0.0646 estimate
- high13F: large reduction
TWO SIGMA INVESTMENTS, LP cut 60% of CGTX (2026Q1)
- mediumEarnings above estimates
Q3-2025: Beat consensus by 41.2% - EPS $-0.06 vs $-0.102 estimate
- mediumEarnings above estimates
Q4-2025: Beat consensus by 43.5% - EPS $-0.048 vs $-0.085 estimate
FREE, NO ACCOUNT
Every event on CGTX, as it fires
New filings, 13F moves and cross asset events on CGTX land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
CGTX positions held by the managers we follow (2026Q3)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP 19243B102 · 2026Q3 | $564K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, CGTX
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
More data on CGTX
CGTX against its peers
CGTX's return on equity of -68.5% ranks in the 55th percentile of 18 Biotechnology sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-04-30.
| Metric | CGTX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 24.1M | n/a | 12 |
| Operating margin | n/a | -197.4% | n/a | 12 |
| Net margin | n/a | -173.6% | n/a | 12 |
| Return on equity | -68.5% | -70.8% | 55 | 18 |
| 1 year | -54.0% | -36.2% | 40 | 20 |
Peers (21): RANI, CRDF, MIST, FBIO, MAIA, COYA, CING, XBIT, CSBR, ACRV, NTRB, HRTX, SPRO, MNOV, GOSS, ONCY, CRBP, BOLD, XLO, SMNR, VRCA. Left out: TNXP (no annual filing), CNXU (no annual filing), APLM (period gap), TLSA (period gap). Fiscal periods ending between 2025-12-31 and 2026-04-30. Every figure is one full fiscal year read from one annual filing (CGTX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in CGTX on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on CGTX in the last 180 days.
Upstream: SEC EDGAR filings for CGTX
Kresmion, "COGNITION THERAPEUTICS INC (CGTX) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/CGTX. Upstream data: SEC EDGAR filings for CGTX.
Link to this data (HTML):
<a href="https://kresmion.com/research/CGTX">COGNITION THERAPEUTICS INC (CGTX) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow CGTX on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to CGTX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.